MATERNAL AND PERINATAL OUTCOMES IN EARLY AND LATE PREECLAMPSIA


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Great attention is paid to the study of early and late preeclampsia (PE). It is known that PE can lead to poor perinatal outcomes; however, the impact of the time of PE manifestation on maternal and perinatal outcomes has been understudied, making it difficult to predict pregnancy outcomes in this group of patients. Objective. To conduct a comprehensive study of the course of pregnancy, maternal and perinatal outcomes, and the neonatal period in patients with early and late PE. Subjects and methods. The prospective cohort study enrolled 70 patients, including 40 patients with early PE (Group 1) and 30 patients with late PE (Group 2). Results. Patients with early PE suffered from chronic hypertension 2.63 times more often and had a history of PE 5.25 times more frequently. In these patients, the average times of admission and delivery were shorter. The patients with early PE were noted to have placental insufficiency and fetal growth retardation 10.5 and 3.8 times more commonly. There were no differences in the severity of hypertension and in the indicators of kidney function between the groups. The patients with early PE showed an increase in the level of liver enzymes (alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase) and a decrease in the count of platelets, although their mean levels remained within the reference values. The cesarean delivery rate was not significantly different between the groups. However, the effect of the therapy was absent and the severity of placental insufficiency was increased in early PE. The babies in the early PE group had lower birth weights (1895±1018 vs 2890±587g; p < 0.001), one- and five-minute Apgar scores (7±1.2 vs 7.7±0.7;p < 0.001) and (8±1.0 vs 87±0.5;p < 0.001), respectively. In addition, the infants in this group frequently needed treatment in the neonatal intensive care unit. Conclusion. The traditional approach is inadequate in predicting complications and perinatal outcomes in the two phenotypic variants of PE, as these classical clinical manifestations of this complication as hypertension and proteinuria are not decisive in characterizing the severity of the condition. The most important clinical feature of early PE is its earlier onset and long duration and the high frequency of metabolic disorders and placental insufficiency, which must be considered when determining the severity of the pathological process. In this connection, the perinatal outcomes in early PE were significantly poorer than those in late PE. It is necessary to continue investigations of the specific features of early PE and an expansion of a range of laboratory and instrumental methods for the early detection of characteristic homeostatic disorders.

Full Text

Restricted Access

About the authors

Galina Vladimirovna Khlestova

Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: g_khlestova@oparina4.ru
postgraduate student Moscow 117997, Ac. Oparina str. 4, Russia

Anna Ovikovna Karapetyan

Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: anne-89@mail.ru
postgraduate student Moscow 117997, Ac. Oparina str. 4, Russia

Marika Nygzarovna Shakaya

Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: shaka-maka@mail.ru
postgraduate student Moscow 117997, Ac. Oparina str. 4, Russia

Andrey Yurievich Romanov

Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: romanov1553@yandex.ru
clinical resident Moscow 117997, Ac. Oparina str. 4, Russia

Oleg Radomirovich Baev

Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: o_baev@oparina4.ru
MD, Professor, Head of maternity department Moscow 117997, Ac. Oparina str. 4, Russia

References

  1. Федеральные клинические рекомендации. Гипертензивные расстройства во время беременности, в родах и послеродовом периоде. Преэклампсия. Эклампсия. М.; 2013: 1-85.
  2. Say L., Chou D., Gemmill A., Tunçalp Ö., Moller A.-B., Daniels J. et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob. Health. 2014; 2(6): e323-33.
  3. Redman C.W.G., Sargent I.L. Placental stress and pre-eclampsia: a revised view. Placenta. 2009; 30(Suppl. A): S38-42.
  4. Ходжаева З., Холин А., Вихляева Е. Ранняя и поздняя преэклампсия: парадигмы патобиологии и клиническая практика. Акушерство и гинекология. 2013; 10: 4-11.
  5. Кан Н.Е., Беднягин Л.А., Долгушина Н.В., Тютюнник В.Л., Ховхаева П.А., Сергунина О.А., Тютюнник Н.В., Амирасланов Э.Ю. Клинико-анамнестические факторы риска развития преэклампсии у беременных. Акушерство и гинекология. 2016; 6: 39-44. http://dx.doi.org/10.18565/ aig.2016.6.39-44
  6. Tsiakkas A., Saiid Y., Wright A., Wright D., Nicolaides K.H. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks’ gestation. Am. J. Obstet. Gynecol. 2016; 215(1): 87. e1-87. e17.
  7. Ходжаева З.С., Коган Е.А., Клименченко Н.И., Акатьева А.С., Сафонова А.Д., Холин А.М., Вавина О.В., Сухих Г.Т. Клинико-патогенетические особенности ранней и поздней преэклампсии. Акушерство и гинекология. 2015; 1: 12-7.
  8. Li X.L., Guo P.L., Xue Y., Gou W.L., Tong M., Chen Q. An analysis of the differences between early and late preeclampsia with severe hypertension. Pregnancy Hypertens. 2016; 6(1): 47-52.
  9. Madazli R., Yuksel M.A., Imamoglu M., Tuten A., Oncul M., Aydin B. et al. Comparison of clinical and perinatal outcomes in early- and late-onset preeclampsia. Arch. Gynecol. Obstet. 2014; 290(1): 53-7.
  10. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 125: Chronic hypertension in pregnancy. Obstet. Gynecol. 2012; 119(2, Pt 1): 396-407.
  11. Magee L.A., Pels A., Helewa M., Rey E., von Dadelszen P.; Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J. Obstet. Gynaecol. Can. 2014; 36(5): 416-41.
  12. National Collaborating Centre for Women’s and Children’s Health (UK). Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. London: RCOG Press; 2010.
  13. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet. Gynecol. 2013; 122(5): 1122-31.
  14. Ni Y., Cheng W. Comparison of indications of pregnancy termination and prognosis of mothers and neonates in early- and late-onset preeclampsia. Hypertens Pregnancy. 2016; 35(3): 315-22.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies